Catalyst Wire Dossier Catalyst Wire Dossier

Melphalan/Hepatic Delivery System

melphalan · Delcath Systems Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Melphalan/Hepatic Delivery System, covering 2023-12-21 to 2023-12-21. Get the full timeline:

Most recent: Clinical Trial Update: An Open-Label Expanded Access Study of the Melphalan/Hepatic Delivery System (HDS) in Patients With Hepatic Dominant Ocular Melanoma [Phase 3]

See pricing